Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
329.59
-2.11 (-0.64%)
At close: May 11, 2026, 4:00 PM EDT
329.76
+0.17 (0.05%)
After-hours: May 11, 2026, 7:56 PM EDT

Amgen Revenue

Amgen had revenue of $8.62B in the quarter ending March 31, 2026, with 5.76% growth. This brings the company's revenue in the last twelve months to $37.22B, up 9.07% year-over-year. In the year 2025, Amgen had annual revenue of $36.75B with 9.95% growth.

Revenue (ttm)
$37.22B
Revenue Growth
+9.07%
P/S Ratio
4.78
Revenue / Employee
$1,181,587
Employees
31,500
Market Cap
177.88B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202536.75B3.33B9.95%
Dec 31, 202433.42B5.23B18.57%
Dec 31, 202328.19B1.87B7.09%
Dec 31, 202226.32B344.00M1.32%
Dec 31, 202125.98B555.00M2.18%
Dec 31, 202025.42B2.06B8.83%
Dec 31, 201923.36B-385.00M-1.62%
Dec 31, 201823.75B898.00M3.93%
Dec 31, 201722.85B-142.00M-0.62%
Dec 31, 201622.99B1.33B6.14%
Dec 31, 201521.66B1.60B7.97%
Dec 31, 201420.06B1.39B7.43%
Dec 31, 201318.68B1.41B8.17%
Dec 31, 201217.27B1.68B10.80%
Dec 31, 201115.58B529.00M3.51%
Dec 31, 201015.05B411.00M2.81%
Dec 31, 200914.64B-361.00M-2.41%
Dec 31, 200815.00B232.00M1.57%
Dec 31, 200714.77B503.00M3.53%
Dec 31, 200614.27B1.84B14.79%
Dec 31, 200512.43B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Johnson & Johnson96.36B
Merck & Co.65.77B
Pfizer63.32B
AbbVie62.82B
AstraZeneca60.44B
Novartis AG56.58B
Sanofi54.60B
Novo Nordisk50.57B
Revenue Rankings